Home > M&A deals 2013 > Percipient Capital acquires Elucigene Diagnostics
Buyout (LBO, MBO, MBI) · Healthcare Services · October 2013

Percipient Capital acquires Elucigene Diagnostics

On October 17, 2013, Percipient Capital acquired Elucigene Diagnostics, a healthcare services company in United Kingdom.

Deal at a glance

AnnouncedOctober 17, 2013 TypeBuyout (LBO, MBO, MBI) TargetElucigene Diagnostics Buyer Percipient Capital SectorHealthcare Services LocationUnited Kingdom ValueNot disclosed

Target company

Elucigene Diagnostics
United Kingdom
Healthcare Servicessector
-founded
Activestatus
View the company profile →

Buyer

Company · 5 deals on record
  • 1st transaction in healthcare services
  • 2nd transaction in United Kingdom
5deals, all time
3in this sector
2014latest

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

Todays Dental Group Ltd.Same sector and country · May 2022
HomeLink Healthcare Ltd.Same sector and country · Apr 2022
Rodericks Dental Ltd.Same sector and country · Mar 2022

Questions about this deal

Who acquired Elucigene Diagnostics?Percipient Capital acquired Elucigene Diagnostics on October 17, 2013.

What type of deal was it?It was a buyout (lbo, mbo, mbi) in the healthcare services sector in 2013.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).